Variation in Inflammatory Markers and Glycemic Parameters After 12 Months of Exenatide Plus Metformin Treatment Compared with Metformin Alone: A Randomized Placebo‐Controlled Trial
Year: 2013
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.1002/phar.1301
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: exenatide, metformin, type 2 diabetes, inflammatory markers, beta-cell function, glycemic control, insulin sensitivity, resistin, vaspin, chemerin, C-peptide, glucagon, proinsulin, HOMA-β, insulin resistance, GLP-1 receptor agonists, combination therapy, hyperinsulinemic-euglycemic clamp, hyperglycemic clamp, arginine stimulation
Open Access status: closed
OpenAlex ID: W2036806748
